Test of association between variant TG?1 alleles and late adverse effects of breast radiotherapy

Test of association between variant TG?1 alleles and late adverse effects of breast radiotherapy

Purpose: to test for association between single nucleotide polymorphisms at the TGF?1 locus and the risk of late normal tissue injury following whole breast radiotherapy. Methods: a retrospective study compared the number of variant alleles at ?509 and codons 10 and 25 of the TGF?1 locus in women f...

Full description

Bibliographic Details
Main Authors:	Martin, S. (Author), Sydenham, M. (Author), Haviland, J.S (Author), A'Hern, R. (Author), Owen, R. (Author), Bliss, J. (Author), Yarnold, J. (Author)
Format:	Article
Language:	English
Published:	2010-10.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

Late effects of breast radiotherapy
by: Haviland, J.S, et al.
Published: (2014)

Intraoperative radiotherapy for early breast cancer
by: Haviland, J.S, et al.
Published: (2010)

Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.
by: Yarnold, J., et al.
Published: (2005)

Evaluation of method for grading late photographic change in breast appearance after radiotherapy for early breast cancer
by: Haviland, J.S, et al.
Published: (2008)

Do patient-reported outcome measures agree with clinical and photographic assessments of normal tissue effects after breast radiotherapy? The experience of the standardisation of breast radiotherapy (START) trials in early breast cancer
by: Haviland, J.S, et al.
Published: (2016)

Intraoperative radiotherapy for breast cancer
by: Haviland, J.S, et al.
Published: (2014)

Radiotherapy for breast cancer, the TARGIT-A trial
by: Haviland, J.S, et al.
Published: (2014)

Hypofractionated radiotherapy for breast cancer
by: Haviland, J.S, et al.
Published: (2010)

TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early stage breast cancer
by: Andreassen, C.N, et al.
Published: (2005)

Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and on delivery, the main explanation? on behalf of the FAST Trialists' Group.
by: Goldsmith, C., et al.
Published: (2011)

Ipsilateral breast tumour relapse: local recurrence versus new primary and the effect of whole breast radiotherapy on the rate of new primaries
by: Gujral, D.M, et al.
Published: (2011)

Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities
by: Yarnold, J., et al.
Published: (2011)

Letter. Intensity-modulated radiotherapy for the treatment of breast cancer
by: Coles, C.E, et al.
Published: (2013)

Does breast composition influence late adverse effects in breast radiotherapy?
by: Juneja, Prabhjot, et al.
Published: (2016)

DCIS II trial: a randomised trial testing observation (no radiotherapy) against radiotherapy in women with low-risk completely excised oestrogen receptor (ER) positive ductal carcinoma in situ (DCIS) of the breast on adjuvant endocrine therapy.
by: Yarnold, J., et al.
Published: (2004)

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy
by: Westbury, C.B, et al.
Published: (2014)

Dose and fractionation regimens for breast cancer - Authors' reply
by: Yarnold, J.R, et al.
Published: (2006)

The Impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy
by: Tsang, Y.M, et al.
Published: (2012)

The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy) Trial
by: Hopwood, P., et al.
Published: (2007)

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
by: Bentzen, S.M, et al.
Published: (2008)

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial
by: Owen, J.R, et al.
Published: (2006)

The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results of the UK Standardisation of Radiotherapy Trials (START)
by: Hopwood, P., et al.
Published: (2010)

Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer
by: Martin, S., et al.
Published: (2008)

Radiotherapy Delivery for Women withEarly Breast Cancer
by: John Yarnold
Published: (2010-07-01)

Polymorphisms in antioxidant genes as predictive factors of radiotherapy late skin adverse events in breast cancer patients
by: T. Marinko, et al.
Published: (2021-04-01)

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015): The FAST Trialists group
by: Agrawal, R.K, et al.
Published: (2011)

Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort
by: Watson, M., et al.
Published: (2005)

The UK HeartSpare study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy
by: Bartlett, F.R, et al.
Published: (2013)

Influence of psychological response on survival in breast cancer: a population-based cohort study
by: Watson, M., et al.
Published: (1999)

Late dermal effects of breast cancer radiotherapy
by: Riekki, R. (Riitta)
Published: (2006)

The role of lymphocytes in radiotherapy-induced adverse late effects in the lung
by: Florian Wirsdörfer, et al.
Published: (2016-12-01)

Psychological response and survival in breast cancer - reply
by: Watson, M., et al.
Published: (2000)

Fighting spirit in patients with cancer - reply
by: Watson, M., et al.
Published: (2000)

A high-carbohydrate diet enhances the adverse effect of the S2 allele of APOC3 SstI polymorphism on the TG/HDL-C ratio only in young Chinese females
by: Yong Yan Song, et al.
Published: (2011-06-01)

A high-carbohydrate diet enhances the adverse effect of the S2 allele of APOC3 SstI polymorphism on the TG/HDL-C ratio only in young Chinese females
by: Yong Yan Song, et al.
Published: (2011-06-01)

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity
by: Barnett, Gillian C., et al.
Published: (2014)

An allelic variant of congenital Salih myopathy
by: M. S. Belenikin, et al.
Published: (2016-03-01)

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy
by: Harris, Emma J., et al.
Published: (2016)

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
by: L. N. Lyubchenko, et al.
Published: (2017-10-01)

Study results should not have been dismissed (letter)
by: Watson, M.A, et al.
Published: (2003)